Dietrich John Pauls serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Dietrich John Pauls has executed 5 insider transactions totaling $112.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 23, 2023 involved purchasing 12,787 shares valued at $50.0K.
Dietrich John Pauls currently holds 68,591 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dietrich John Pauls has been a net buyer of DMAC stock. They have purchased $112.6K and sold $0 worth of shares.
Dietrich John Pauls's most recent insider trade was on Jun 23, 2023, when they purchased 12,787 shares at $3.91 per share.
Get notified when new Form 4 filings are submitted
| $1.21 |
| Discretionary |
| Aug 16, 2021 | DMAC | $15.7K | Purchase | 5,000 | $3.14 | Discretionary |
| Aug 16, 2019 | DMAC | $2.7K | Purchase | 1,000 | $2.68 | Discretionary |
| Dec 11, 2018 | DMAC | $20.0K | Purchase | 5,000 | $4.00 | Discretionary |